Cargando…
Risk of multiple myeloma and other malignancies among first‐ and second‐degree relatives of patients with multiple myeloma: A population‐based study
OBJECTIVES: We conducted a population‐based study to assess the risk for multiple myeloma (MM) and other cancers in first‐ and second‐degree relatives of MM patients, and to investigate whether evidence of anticipation is present in familial MM. METHODS: We retrieved 24 845 first‐degree relatives an...
Autores principales: | Langseth, Øystein O., Myklebust, Tor Å., Johannesen, Tom B., Hjertner, Øyvind, Waage, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310738/ https://www.ncbi.nlm.nih.gov/pubmed/35184337 http://dx.doi.org/10.1111/ejh.13757 |
Ejemplares similares
-
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
por: Avivi, Irit, et al.
Publicado: (2023) -
Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018
por: Wang, Jing, et al.
Publicado: (2022) -
Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017) -
P950: COMBINED PROTEASOME AND AUTOPHAGY INHIBITION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA – A PHASE I TRIAL OF HYDROXYCHLOROQUINE, CARFILZOMIB AND DEXAMETHASONE
por: Slørdahl, T. S., et al.
Publicado: (2022) -
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)